The Latest Breaking News from FDA

Biden's announcement of federal cannabis pardons and a review of the CSA scheduling of cannabis produced a whopping 32.4% pop in the MSOS ETF for the week, easily the largest gain since the ETF was created. After a 10-point retracement, MSOs remain over 20% higher.

Tweaked boosters rolled out for Americans 12 and older last month, modified to target today's most common and contagious variant. The latest move may expand protection before an expected winter wave.

The booster shots are now authorized for children as young as 5 years old.

The U.S. is about to offer updated COVID-19 booster shots to kids as young as 5

FDA Names Ex-NY Cannabis Policy Regulator As Advisor On Cannabis Research

UK psychedelics clinical research organization Clerkenwell Health raised $2.047.710 (£2.1 million) in seed funding, bringing the total to date up to $2.437.750 (£2.5 million), all of which will be used to get the London-based startup fully operational.

Häagen-Dazs ice cream products worth 12 million baht were destroyed at an industrial facility in Samut Prakan on Monday although their samples were not found to be contaminated with traces of a chemical linked to a cancer.

ORLANDO, Fla. — The Food and Drug Administration on Monday responded to the results of Florida Surgeon General Joseph Ladapo’s analysis of COVID-19 data that he says point to a risk for some men who get the shot.

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 30 points on Monday.

U.S. stocks pared gains midway through trading, with the Dow Jones dropping more than 100 points on Monday.

Government initiatives to expand domestic biotech production and research and rising private investments in advancing technologies are expected to boost the industry’s prospects. While we believe biotech stocks Vertex Pharmaceuticals (VRTX) and Biogen (BIIB) could be ideal investments for the long run, fundamentally weak Timber Pharmaceuticals (TMBR) might be best…